Literature DB >> 12160123

Clinical practice guidelines for the care and treatment of breast cancer: mastectomy or lumpectomy? The choice of operation for clinical stages I and II breast cancer (summary of the 2002 update).

Hugh Scarth1, Jacques Cantin, Mark Levine.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12160123      PMCID： PMC117094     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  10 in total

Review 1.  The management of chronic pain in patients with breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Society of Palliative Care Physicians. Canadian Association of Radiation Oncologists.

Authors: 
Journal:  CMAJ       Date:  1998-02-10       Impact factor: 8.262

2.  Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial.

Authors:  J A van Dongen; A C Voogd; I S Fentiman; C Legrand; R J Sylvester; D Tong; E van der Schueren; P A Helle; K van Zijl; H Bartelink
Journal:  J Natl Cancer Inst       Date:  2000-07-19       Impact factor: 13.506

3.  Conservation approaches for the management of stage I/II carcinoma of the breast: Milan Cancer Institute trials.

Authors:  U Veronesi; A Luini; V Galimberti; S Zurrida
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

4.  Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma.

Authors:  E R Fisher; J Dignam; E Tan-Chiu; J Costantino; B Fisher; S Paik; N Wolmark
Journal:  Cancer       Date:  1999-08-01       Impact factor: 6.860

5.  Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.

Authors:  B Fisher; J Dignam; N Wolmark; D L Wickerham; E R Fisher; E Mamounas; R Smith; M Begovic; N V Dimitrov; R G Margolese; C G Kardinal; M T Kavanah; L Fehrenbacher; R H Oishi
Journal:  Lancet       Date:  1999-06-12       Impact factor: 79.321

6.  Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18.

Authors:  N Wolmark; J Wang; E Mamounas; J Bryant; B Fisher
Journal:  J Natl Cancer Inst Monogr       Date:  2001

7.  Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902.

Authors:  J A van der Hage; C J van de Velde; J P Julien; M Tubiana-Hulin; C Vandervelden; L Duchateau
Journal:  J Clin Oncol       Date:  2001-11-15       Impact factor: 44.544

8.  Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer.

Authors:  B Fisher; S Anderson; C K Redmond; N Wolmark; D L Wickerham; W M Cronin
Journal:  N Engl J Med       Date:  1995-11-30       Impact factor: 91.245

9.  Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

Authors:  B Fisher; J Bryant; N Wolmark; E Mamounas; A Brown; E R Fisher; D L Wickerham; M Begovic; A DeCillis; A Robidoux; R G Margolese; A B Cruz; J L Hoehn; A W Lees; N V Dimitrov; H D Bear
Journal:  J Clin Oncol       Date:  1998-08       Impact factor: 44.544

10.  Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer.

Authors:  J A van Dongen; H Bartelink; I S Fentiman; T Lerut; F Mignolet; G Olthuis; E van der Schueren; R Sylvester; D Tong; J Winter
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162
  10 in total
  11 in total

1.  Caution with breast-conserving surgery.

Authors:  Theodore A Vandenberg; Vivian H Bramwell
Journal:  CMAJ       Date:  2002-11-12       Impact factor: 8.262

2.  Decision aids in routine practice: lessons from the breast cancer initiative.

Authors:  Kerry A Silvia; Karen R Sepucha
Journal:  Health Expect       Date:  2006-09       Impact factor: 3.377

3.  Cost-effectiveness of positron emission tomography in breast cancer.

Authors:  J Scott Sloka; Peter D Hollett; Maria Mathews
Journal:  Mol Imaging Biol       Date:  2005 Sep-Oct       Impact factor: 3.488

4.  Quality of diagnosis and surgical management of breast lesions in a community hospital: room for improvement?

Authors:  Catherine Hanley; Robert Kessaram
Journal:  Can J Surg       Date:  2006-06       Impact factor: 2.089

5.  High efficacy of a Listeria-based vaccine against metastatic breast cancer reveals a dual mode of action.

Authors:  Sun Hee Kim; Francisco Castro; Yvonne Paterson; Claudia Gravekamp
Journal:  Cancer Res       Date:  2009-07-07       Impact factor: 12.701

6.  Rates of breast cancer surgery in Canada from 2007/08 to 2009/10: retrospective cohort study.

Authors:  Geoff Porter; Brandon Wagar; Heather Bryant; Maria Hewitt; Elaine Wai; Kelly Dabbs; Anne McFarlane; Rami Rahal
Journal:  CMAJ Open       Date:  2014-06-17

7.  Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients.

Authors:  Sarah T Hawley; Jennifer J Griggs; Ann S Hamilton; John J Graff; Nancy K Janz; Monica Morrow; Reshma Jagsi; Barbara Salem; Steven J Katz
Journal:  J Natl Cancer Inst       Date:  2009-08-31       Impact factor: 13.506

8.  Reoperation rates after breast conserving surgery for breast cancer among women in England: retrospective study of hospital episode statistics.

Authors:  R Jeevan; D A Cromwell; M Trivella; G Lawrence; O Kearins; J Pereira; C Sheppard; C M Caddy; J H P van der Meulen
Journal:  BMJ       Date:  2012-07-12

9.  Mage-b vaccine delivered by recombinant Listeria monocytogenes is highly effective against breast cancer metastases.

Authors:  S H Kim; F Castro; D Gonzalez; P C Maciag; Y Paterson; C Gravekamp
Journal:  Br J Cancer       Date:  2008-08-19       Impact factor: 7.640

10.  Vaccination with Mage-b DNA induces CD8 T-cell responses at young but not old age in mice with metastatic breast cancer.

Authors:  F Castro; B Leal; A Denny; R Bahar; S Lampkin; R Reddick; S Lu; C Gravekamp
Journal:  Br J Cancer       Date:  2009-09-29       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.